Adequate Engraftment with Lower Hematopoietic Stem Cell Dose
ConclusionsASCT can be safely performed even with lower HSC dose in non-cryopreserved setting.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants